Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fri, 07/26/24 - 11:29 am
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Eisai adopts Medidata’s AI-driven platform for clinical trials
Clinical Trials Arena
Fri, 07/26/24 - 11:13 am
Eisai
Medidata
clinical trials
artificial intelligence
Abbott recalls Freestyle Libre 3 sensors due to incorrect glucose readings
Medtech Dive
Fri, 07/26/24 - 11:11 am
Abbott Labs
Medtech
device recalls
CGMs
FreeStyle Libre 3
Cue Biopharma downsizes to focus on autoimmune pipeline
Clinical Trials Arena
Fri, 07/26/24 - 11:09 am
Cue Biopharma
autoimmune disease
layoffs
Calliditas' liver disease trial hits primary endpoint after sweeping changes to design
Fierce Biotech
Fri, 07/26/24 - 11:08 am
Calliditas
liver disease
primary biliary cholangitis
clinical trials
setanaxib
BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues
BioSpace
Fri, 07/26/24 - 11:06 am
Bristol Myers Squibb
earnings
Big Pharma Appears to Be Unfazed by IRA Drug Price Negotiations
BioSpace
Fri, 07/26/24 - 11:05 am
Big Pharma
drug pricing
Inflation Reduction Act
Clinical trial diversity is a balancing act of time, quality, and money
Clinical Trials Arena
Fri, 07/26/24 - 11:04 am
clinical trials
clinical trial diversity
FDA
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
Indivior reaches $86 million opioid settlement with US states
Reuters
Fri, 07/26/24 - 11:01 am
Indivior
legal
opioids
opioid crisis
Citius’ first FDA decision date is approaching — and its CEO has millions on the line
Pharma Voice
Fri, 07/26/24 - 10:59 am
Citius Pharmaceuticals
Lymphir
FDA
persistent or recurrent cutaneous T-cell lymphoma
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive
Thu, 07/25/24 - 10:05 pm
Roche
obesity
Carmot Therapeutics
CT-388
CT-996
Pfizer quickly expands its hemophilia B gene therapy's reach with EU approval
Fierce Pharma
Thu, 07/25/24 - 10:02 pm
Pfizer
hemophila B
Beqvez
Durveqtix
Europe
FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trials
Fierce Pharma
Thu, 07/25/24 - 09:59 pm
FDA
ODAC
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
A public health call to arms: The long build to FDA’s misinformation guidance
Medical Marketing and Media
Thu, 07/25/24 - 09:58 pm
misinformation
regulatory
FDA
Dexcom shares plunge after it cuts annual revenue forecast
Reuters
Thu, 07/25/24 - 09:57 pm
DexCom
earnings
Medtech
Non-Hodgkin’s lymphoma trials increase in the 5 years since 2019
Clinical Trials Arena
Thu, 07/25/24 - 09:43 pm
non-Hodgkin's lymphoma
clinical trials
July 25 2024 - Trials to watch: Four biologics concluding pivotal COPD trials
Thu, 07/25/24 - 11:39 am
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »